₹0
9M+ Happy Customers
100% Authentic
Quality Checked ProductsIntroduction About TELMIJUB CH 80/12.5MG TABLET
TELMIJUB CH 80/12.5MG TABLET is used to manage hypertension (high blood pressure) in affected individuals when monotherapy with chlorthalidone or telmisartan becomes inadequate to control the condition. It is also used as initial therapy in patients who are indicated for multiple drug therapy to control high blood pressure. It is a combination of Chlorthalidone and Telmisartan which belongs to the group of medicines called Diuretics and Angiotensin II receptor blockers, respectively.
TELMIJUB CH 80/12.5MG TABLET is not recommended for use in patients who are allergic to chlorthalidone, telmisartan, and/or any sulphonamide-derived medicines. It is also not recommended for use in patients suffering from anuria and severe liver impairment. Before taking the medicine, inform your doctor if you have liver problems, kidney problems and/or heart problems (such as congestive heart failure).
TELMIJUB CH 80/12.5MG TABLET is not recommended for use during pregnancy and in women planning for pregnancy. It is also not recommended for use in breastfeeding women since it passes through breast milk. It should be used with caution in children and adolescents (aged 6 to 18 years) and in elders (aged 65 years and above). The most common side effects are back pain, sore throat, nausea, abdominal pain, indigestion, diarrhoea, and/or headache. Consult your doctor if any of these symptoms worsen.
Uses Of TELMIJUB CH 80/12.5MG TABLET
- Used to manage hypertension
How TELMIJUB CH 80/12.5MG TABLET Works
TELMIJUB CH 80/12.5MG TABLET helps to lower blood pressure, where telmisartan works by blocking angiotensin (a hormone responsible for regulating blood pressure and maintaining fluid balance in the body) which leads to relaxation of blood vessels and Chlorthalidone works by removing extra water and certain electrolytes from the body which leads to relaxation of blood pressure and improved blood flow thus reducing high blood pressure in affected individuals.
How to use TELMIJUB CH 80/12.5MG TABLET
- Take TELMIJUB CH 80/12.5MG TABLET as advised by your physician
- Swallow the medicine with a glass of water. Do not crush or chew the medicine
- Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition
Side Effects Of TELMIJUB CH 80/12.5MG TABLET
Common side effects of TELMIJUB CH 80/12.5MG TABLET:
- back pain
- abdominal pain, indigestion
- diarrhoea
- headache, dizziness, feeling weak
- dry mouth
Stop taking TELMIJUB CH 80/12.5MG TABLET and contact your doctor immediately if you experience any of the following side effects:
- Signs of hypokalaemia (low potassium level in blood) such as muscular weakness, racing heartbeat, extreme tiredness
Warning & Precautions
Pregnancy
Consult your doctorIf you are pregnant women, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Breastfeeding
Consult your doctorIf you are a breastfeeding women, ask your doctor for advice before taking this medicine.
Kidney
Use with CautionTELMIJUB CH 80/12.5MG TABLET should be used with caution in patients undergoing haemodialysis and in patients with kidney problems such as decreased renal function, severe renal impairment, and nephrogenic diabetes insipidus.
Liver
Consult your doctorTELMIJUB CH 80/12.5MG TABLET is not recommended for use in patients with severe liver impairment. It should be taken with caution in patients with liver disease such as mild to moderate hepatic impairment.
Allergy
ContraindicatedDo not take TELMIJUB CH 80/12.5MG TABLET if you are allergic to chlorthalidone, telmisartan or any other ingredients of this medicine.
Heart Disease
Use with CautionTELMIJUB CH 80/12.5MG TABLET should be used with caution in patients with heart diseases such as congestive heart failure.
Use In Pediatrics
Use with CautionTELMIJUB CH 80/12.5MG TABLET should be used with caution in children and adolescents (aged 6 to 18 years).
Use In Geriatrics
Use with CautionTELMIJUB CH 80/12.5MG TABLET should be used with caution in elderly patients (aged above 65 years).
Others
TELMIJUB CH 80/12.5MG TABLET is not recommended for use if you:
- have anuria (failure of kidneys to produce urine)
Interactions
A. Drug-Drug interactions:
Before taking TELMIJUB CH 80/12.5MG TABLET, inform your doctor if you are taking any of the following medicine:
- Anti-hypertensive agents (Ex. aliskiren, ramipiril, guanethidine, methyldopa)
- Cardiac glycosides (Ex. Digoxin)
- Anti-maniac agents (Ex. Lithium)
- Selective COX-2 inhibitors (Ex. celecoxib, indometacin)
- Anti-diabetics (Ex. metformin, glibenclamide, insulin)
- Anti-cholinergic agents (Ex. atropine, biperiden)
- Calcium salts, Vitamin D
- Immunosuppressants (Ex. Cyclosporin)
- β-blockers (Ex. acebutolol, atenolol)
- Vasodilators (Ex. benazepril, lisinopril)
- calcium antagonists (Ex. amlodipine, diltiazem)
- ACE inhibitors (Ex. benazepril, captopril)
- Anti-lipidemic agents (Ex. Cholestyramine)
- Corticosteroids (Ex. prednisolone)
- Beta-2 agonists (Ex. salbutamol, terbutaline)
- Antifungals (Ex. Amphotericin)
- Triterpenoids (Ex. Carbenoxolone)
- Cardiac glycosides (Ex. Digitalis)
- Xanthine oxidase inhibitor (Ex. Allopurinol)
- Adamantanes (Ex. Amantadine)
- Benzothiadiazine (Ex. Diazoxide)
- Cytotoxic agents (Ex. cyclophosphamide, methotrexate)
B. Drug-Food interaction:
Avoid having very strict low-salt diet while taking TELMIJUB CH 80/12.5MG TABLET since it may cause undesirable effects.
Overdosage:
If you or anyone else accidentally take too much of the medicine, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are low blood pressure, dizziness, fast heart rate, slow heart rate, nausea, sleeplessness, hypovolaemia (low blood volume), and electrolyte imbalances (associated with an irregular heartbeat and muscle spasms).
Synopsis
| Drug | : | Chlorthalidone, Telmisartan |
| Pharmacological Category | : | Diuretics, Angiotensin II receptor blockers |
| Therapeutic Indication | : | Hypertension |
| Dosage Forms | : | Tablet |
More Information
FAQs About TELMIJUB CH 80/12.5MG TABLET
Q: What is TELMIJUB CH 80/12.5MG TABLET used for?
A: TELMIJUB CH 80/12.5MG TABLET is used to manage essential hypertension (high blood pressure) in affected individuals when monotherapy with chlorthalidone or telmisartan becomes inadequate to control the condition.
Q: How does TELMIJUB CH 80/12.5MG TABLET works?
A: TELMIJUB CH 80/12.5MG TABLET helps to lower blood pressure, whereas telmisartan works by blocking angiotensin (a hormone responsible for regulating blood pressure and maintaining fluid balance in the body) which leads to the relaxation of blood vessels and chlorthalidone works by removing extra water and certain electrolytes from the body which leads to relaxation of blood pressure and improved blood flow thus reducing high blood pressure in affected individuals.
Q: How is TELMIJUB CH 80/12.5MG TABLET taken?
A: Take TELMIJUB CH 80/12.5MG TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition.
Q: What are the side effects of TELMIJUB CH 80/12.5MG TABLET?
A: The most common side effects of taking TELMIJUB CH 80/12.5MG TABLET are back pain, sore throat, nausea, abdominal pain, indigestion, diarrhoea, and/or headache. Consult your doctor if any of these symptoms worsen.
Q: What happens if you take more TELMIJUB CH 80/12.5MG TABLET than the required dose?
A: If you or anyone else accidentally take too much of TELMIJUB CH 80/12.5MG TABLET, consult your doctor immediately or visit the nearby hospital. Overdose symptoms are low blood pressure, dizziness, fast heart rate, slow heart rate, nausea, sleeplessness, hypovolaemia (low blood volume), and electrolyte imbalances (associated with irregular heartbeat and muscle spasms).
References
1. KD Tripathi. Drugs Affecting Renin - Angiotensin System & Plasma Kinins and Antihypertensive Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 507,559.
2. Suresh V Sagarad, Sudha Biradar Kerure, Chaitanya Kumar S, and Ramakrishna MR. Sagarad Kerure SB, Kumar S C, Mr R. The Antihypertensive Efficacy of Chlorthalidone and Telmisartan in Indian Hypertensive Patients who were Uncontrolled with Hydrochlorothiazide and Telmisartan Combination – A prospective and an open label study. NIH National Library of Medicine. National center for biotechnology Information. February 2013. [Accessed on 10th October 2022] click here
3. Mary M. Stephens, Beth A. Fox, and Lisa Maxwell. Therapeutic Options for the Treatment of Hypertension in Children and Adolescents. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. February 2012. [Accessed on 10th October 2022] click here
4. Steris Healthcare PVT Ltd. Telmistrum CH 6.25. [Accessed on 10th October 2022] click here
5. Wonset Healthcare. TELVOK CH 20. [Accessed on 10th October 2022] click here
6. Ciplamed. CRESAR CT Tablets. [Revised in February 2018] [Accessed on 10th October 2022] click here
7. Ipca Laboratories Ltd. CDT Tablet. [Accessed on 10th October 2022] click here
Author Details
VIDEOS
Chlorthalidone+Telmisartan TABLET - Drug Information
Chlorthalidone+Telmisartan TABLET : Therapeutic Uses, Warning and Precautions, Interactions, Directions for Use, Side Effects and Storage
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
